117 related articles for article (PubMed ID: 9469590)
1. Interleukin-1beta and interleukin-6 increase levels of apolipoprotein B mRNA and decrease accumulation of its protein in culture medium of HepG2 cells.
Yokoyama K; Ishibashi T; Yi-qiang L; Nagayoshi A; Teramoto T; Maruyama Y
J Lipid Res; 1998 Jan; 39(1):103-13. PubMed ID: 9469590
[TBL] [Abstract][Full Text] [Related]
2. The effect of low density lipoproteins, cholesterol, and 25-hydroxycholesterol on apolipoprotein B gene expression in HepG2 cells.
Dashti N
J Biol Chem; 1992 Apr; 267(10):7160-9. PubMed ID: 1313035
[TBL] [Abstract][Full Text] [Related]
3. HepG2 cell LDL receptor activity and the accumulation of apolipoprotein B and E in response to docosahexaenoic acid and cholesterol.
Sorci-Thomas M; Hendricks CL; Kearns MW
J Lipid Res; 1992 Aug; 33(8):1147-56. PubMed ID: 1431595
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroid-binding globulin synthesis regulation by cytokines and glucocorticoids in human hepatoblastoma-derived (HepG2) cells.
Emptoz-Bonneton A; Crave JC; LeJeune H; Brébant C; Pugeat M
J Clin Endocrinol Metab; 1997 Nov; 82(11):3758-62. PubMed ID: 9360537
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta down-regulates apolipoprotein M in HepG2 cells.
Xu N; Hurtig M; Zhang XY; Ye Q; Nilsson-Ehle P
Biochim Biophys Acta; 2004 Jul; 1683(1-3):33-7. PubMed ID: 15238217
[TBL] [Abstract][Full Text] [Related]
6. Effects of platelet-activating factor, tumor necrosis factor, and interleukin-1alpha on the expression of apolipoprotein M in HepG2 cells.
Xu N; Zhang XY; Dong X; Ekström U; Ye Q; Nilsson-Ehle P
Biochem Biophys Res Commun; 2002 Apr; 292(4):944-50. PubMed ID: 11944906
[TBL] [Abstract][Full Text] [Related]
7. Cotranslational inhibition of apoB-100 synthesis by cyclosporin A in the human hepatoma cell line HepG2.
Kaptein A; de Wit EC; Princen HM
Arterioscler Thromb; 1994 May; 14(5):780-9. PubMed ID: 8172854
[TBL] [Abstract][Full Text] [Related]
8. Secretion of apolipoproteins A-I and B by HepG2 cells: regulation by substrates and metabolic inhibitors.
Kempen HJ; Imbach AP; Giller T; Neumann WJ; Hennes U; Nakada N
J Lipid Res; 1995 Aug; 36(8):1796-806. PubMed ID: 7595100
[TBL] [Abstract][Full Text] [Related]
9. ApoB100 secretion from HepG2 cells is decreased by the ACAT inhibitor CI-1011: an effect associated with enhanced intracellular degradation of ApoB.
Wilcox LJ; Barrett PH; Newton RS; Huff MW
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):939-49. PubMed ID: 10195921
[TBL] [Abstract][Full Text] [Related]
10. Niacin accelerates intracellular ApoB degradation by inhibiting triacylglycerol synthesis in human hepatoblastoma (HepG2) cells.
Jin FY; Kamanna VS; Kashyap ML
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1051-9. PubMed ID: 10195935
[TBL] [Abstract][Full Text] [Related]
11. Conformational changes in apolipoprotein B modulate intracellular assembly and degradation of ApoB-containing lipoprotein particles in HepG2 cells.
Macri J; Adeli K
Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2982-94. PubMed ID: 9409285
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-6 mediates hepatic hypersecretion of apolipoprotein B.
Sparks JD; Cianci J; Jokinen J; Chen LS; Sparks CE
Am J Physiol Gastrointest Liver Physiol; 2010 Oct; 299(4):G980-9. PubMed ID: 20651008
[TBL] [Abstract][Full Text] [Related]
13. Effect of ethanol on the synthesis and secretion of apoA-I- and apoB-containing lipoproteins in HepG2 cells.
Dashti N; Franklin FA; Abrahamson DR
J Lipid Res; 1996 Apr; 37(4):810-24. PubMed ID: 8732781
[TBL] [Abstract][Full Text] [Related]
14. ACTH decreases the expression and secretion of apolipoprotein B in HepG2 cell cultures.
Xu N; Ekstrom U; Nilsson-Ehle P
J Biol Chem; 2001 Oct; 276(42):38680-4. PubMed ID: 11514556
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of apolipoprotein B secretion from HepG2 cells by two HMG-CoA reductase inhibitors, atorvastatin and simvastatin.
Wilcox LJ; Barrett PH; Huff MW
J Lipid Res; 1999 Jun; 40(6):1078-89. PubMed ID: 10357840
[TBL] [Abstract][Full Text] [Related]
16. The peroxisome proliferator-activated receptor alpha (PPARalpha) agonist ciprofibrate inhibits apolipoprotein B mRNA editing in low density lipoprotein receptor-deficient mice: effects on plasma lipoproteins and the development of atherosclerotic lesions.
Fu T; Mukhopadhyay D; Davidson NO; Borensztajn J
J Biol Chem; 2004 Jul; 279(27):28662-9. PubMed ID: 15123680
[TBL] [Abstract][Full Text] [Related]
17. Exogenous VLDL stimulates apolipoprotein B secretion from HepG2 cells by both pre- and post-translational mechanisms.
Wu X; Sakata N; Dixon J; Ginsberg HN
J Lipid Res; 1994 Jul; 35(7):1200-10. PubMed ID: 7964181
[TBL] [Abstract][Full Text] [Related]
18. Post-transcriptional stabilization by interleukin-1beta of interleukin-6 mRNA induced by c-kit ligand and interleukin-10 in mouse bone marrow-derived mast cells.
Lu-Kuo JM; Austen KF; Katz HR
J Biol Chem; 1996 Sep; 271(36):22169-74. PubMed ID: 8703029
[TBL] [Abstract][Full Text] [Related]
19. Interleukin-1beta-induced promatrilysin expression is mediated by NFkappaB-regulated synthesis of interleukin-6 in the prostate carcinoma cell line, LNCaP.
Maliner-Stratton MS; Klein RD; Udayakumar TS; Nagle RB; Bowden GT
Neoplasia; 2001; 3(6):509-20. PubMed ID: 11774033
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of apolipoprotein B secretion by IL-6 is mediated by EGF or an EGF-like molecule in CaCo-2 cells.
Murthy S; Mathur S; Bishop WP; Field EJ
J Lipid Res; 1997 Feb; 38(2):206-16. PubMed ID: 9162741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
